Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.73053839 |
2 | Golgi transport vesicle coating (GO:0048200) | 5.58543079 |
3 | COPI coating of Golgi vesicle (GO:0048205) | 5.58543079 |
4 | synaptic vesicle maturation (GO:0016188) | 5.31153224 |
5 | postsynaptic membrane organization (GO:0001941) | 4.91413632 |
6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.75774860 |
7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.61169416 |
8 | positive regulation of synapse maturation (GO:0090129) | 4.34861682 |
9 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 4.29699297 |
10 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.28645615 |
11 | sodium ion export (GO:0071436) | 4.21134346 |
12 | synaptic vesicle exocytosis (GO:0016079) | 4.16290068 |
13 | regulation of synaptic vesicle transport (GO:1902803) | 4.11617776 |
14 | locomotory exploration behavior (GO:0035641) | 4.08516826 |
15 | insulin secretion (GO:0030073) | 4.01238119 |
16 | neuronal ion channel clustering (GO:0045161) | 3.99211182 |
17 | positive regulation of insulin secretion (GO:0032024) | 3.94207019 |
18 | auditory behavior (GO:0031223) | 3.93499240 |
19 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.92444461 |
20 | protein maturation by protein folding (GO:0022417) | 3.91182502 |
21 | establishment of mitochondrion localization (GO:0051654) | 3.86775422 |
22 | central nervous system myelination (GO:0022010) | 3.86009971 |
23 | axon ensheathment in central nervous system (GO:0032291) | 3.86009971 |
24 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.84937693 |
25 | neuronal action potential propagation (GO:0019227) | 3.84169622 |
26 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.83237999 |
27 | positive regulation of dendritic spine development (GO:0060999) | 3.81993698 |
28 | glutamate secretion (GO:0014047) | 3.81009079 |
29 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.78954703 |
30 | neuromuscular process controlling posture (GO:0050884) | 3.76502527 |
31 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.74105619 |
32 | neurotransmitter secretion (GO:0007269) | 3.66566242 |
33 | endocrine pancreas development (GO:0031018) | 3.64592192 |
34 | detection of calcium ion (GO:0005513) | 3.64162106 |
35 | activation of protein kinase A activity (GO:0034199) | 3.63169720 |
36 | cerebellar granule cell differentiation (GO:0021707) | 3.62879816 |
37 | glycine transport (GO:0015816) | 3.62419574 |
38 | * peptide hormone processing (GO:0016486) | 3.60179061 |
39 | protein retention in ER lumen (GO:0006621) | 3.60172044 |
40 | cell migration in hindbrain (GO:0021535) | 3.59968080 |
41 | synaptic vesicle endocytosis (GO:0048488) | 3.59260781 |
42 | positive regulation of vesicle fusion (GO:0031340) | 3.56644354 |
43 | potassium ion homeostasis (GO:0055075) | 3.54939793 |
44 | presynaptic membrane organization (GO:0097090) | 3.52280325 |
45 | regulation of vesicle fusion (GO:0031338) | 3.51730380 |
46 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.51376067 |
47 | cellular response to glucagon stimulus (GO:0071377) | 3.51170129 |
48 | neuron-neuron synaptic transmission (GO:0007270) | 3.49697752 |
49 | presynaptic membrane assembly (GO:0097105) | 3.48375540 |
50 | positive regulation of neurotransmitter transport (GO:0051590) | 3.46109752 |
51 | regulation of insulin secretion (GO:0050796) | 3.45994864 |
52 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.45584520 |
53 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 3.45346812 |
54 | L-amino acid import (GO:0043092) | 3.45002319 |
55 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.44957705 |
56 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.44919694 |
57 | regulation of synapse maturation (GO:0090128) | 3.44489813 |
58 | glutamate receptor signaling pathway (GO:0007215) | 3.43565475 |
59 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.43464840 |
60 | positive regulation of peptide hormone secretion (GO:0090277) | 3.43123752 |
61 | regulation of neurotransmitter transport (GO:0051588) | 3.42396701 |
62 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.41841004 |
63 | positive regulation of peptide secretion (GO:0002793) | 3.41565740 |
64 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.40184957 |
65 | cerebellar Purkinje cell layer development (GO:0021680) | 3.38572045 |
66 | potassium ion import (GO:0010107) | 3.37483242 |
67 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.35070893 |
68 | response to auditory stimulus (GO:0010996) | 3.34380103 |
69 | nucleobase catabolic process (GO:0046113) | 3.32606117 |
70 | chemosensory behavior (GO:0007635) | 3.31157697 |
71 | regulation of postsynaptic membrane potential (GO:0060078) | 3.29961260 |
72 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.29495670 |
73 | transmission of nerve impulse (GO:0019226) | 3.29015273 |
74 | regulation of synaptic plasticity (GO:0048167) | 3.28275391 |
75 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.27870465 |
76 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.25081036 |
77 | amino acid import (GO:0043090) | 3.24095214 |
78 | peptide hormone secretion (GO:0030072) | 3.21593971 |
79 | regulation of peptide hormone secretion (GO:0090276) | 3.19475469 |
80 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.19349367 |
81 | nitric oxide mediated signal transduction (GO:0007263) | 3.17992856 |
82 | regulation of peptide secretion (GO:0002791) | 3.16831959 |
83 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.16539468 |
84 | positive regulation of amino acid transport (GO:0051957) | 3.16223073 |
85 | vocalization behavior (GO:0071625) | 3.16189544 |
86 | neuromuscular process controlling balance (GO:0050885) | 3.15546469 |
87 | regulation of dendritic spine development (GO:0060998) | 3.14489440 |
88 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.14105201 |
89 | axonal fasciculation (GO:0007413) | 3.13164994 |
90 | neuron recognition (GO:0008038) | 3.12207453 |
91 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.11994407 |
92 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.11333241 |
93 | peptide secretion (GO:0002790) | 3.10449950 |
94 | mitochondrion transport along microtubule (GO:0047497) | 3.10120615 |
95 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.10120615 |
96 | exploration behavior (GO:0035640) | 3.09899038 |
97 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.08444964 |
98 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.08106456 |
99 | signal release (GO:0023061) | 3.05660482 |
100 | innervation (GO:0060384) | 3.05283183 |
101 | positive regulation of exocytosis (GO:0045921) | 3.04593999 |
102 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.03703289 |
103 | neuromuscular synaptic transmission (GO:0007274) | 3.01621630 |
104 | establishment of synaptic vesicle localization (GO:0097480) | 2.99296193 |
105 | synaptic vesicle transport (GO:0048489) | 2.99296193 |
106 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.99113079 |
107 | acidic amino acid transport (GO:0015800) | 2.98427689 |
108 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.97787214 |
109 | response to pheromone (GO:0019236) | 2.97188042 |
110 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.96421630 |
111 | glandular epithelial cell differentiation (GO:0002067) | 2.96155082 |
112 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.96122898 |
113 | synapse assembly (GO:0007416) | 2.95869398 |
114 | cell communication by electrical coupling (GO:0010644) | 2.95788766 |
115 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.95630111 |
116 | regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178) | 2.95333787 |
117 | regulation of synapse structural plasticity (GO:0051823) | 2.93927624 |
118 | toxin metabolic process (GO:0009404) | 2.93616027 |
119 | membrane depolarization (GO:0051899) | 2.93417018 |
120 | regulation of norepinephrine secretion (GO:0014061) | 2.92944234 |
121 | vesicle coating (GO:0006901) | 2.92756858 |
122 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.92621989 |
123 | COPII vesicle coating (GO:0048208) | 2.91804466 |
124 | neuron cell-cell adhesion (GO:0007158) | 2.91131688 |
125 | dendritic spine morphogenesis (GO:0060997) | 2.91112093 |
126 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.90990924 |
127 | synaptic transmission (GO:0007268) | 2.90516840 |
128 | protein localization to synapse (GO:0035418) | 2.90041523 |
129 | cellular sodium ion homeostasis (GO:0006883) | 2.89104944 |
130 | neurotransmitter transport (GO:0006836) | 2.87764601 |
131 | regulation of synaptic transmission (GO:0050804) | 2.87632147 |
132 | vesicle transport along microtubule (GO:0047496) | 2.87591805 |
133 | growth hormone secretion (GO:0030252) | 2.87580689 |
134 | membrane hyperpolarization (GO:0060081) | 2.86110155 |
135 | regulation of exocytosis (GO:0017157) | 2.85282090 |
136 | layer formation in cerebral cortex (GO:0021819) | 2.83992372 |
137 | regulation of glucocorticoid secretion (GO:2000849) | 2.81623762 |
138 | regulation of hormone secretion (GO:0046883) | 2.80962665 |
139 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.74405023 |
140 | suckling behavior (GO:0001967) | 2.70651608 |
141 | regulation of beta-amyloid formation (GO:1902003) | 2.69397398 |
142 | positive regulation of membrane potential (GO:0045838) | 2.69292783 |
143 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.68936740 |
144 | gamma-aminobutyric acid transport (GO:0015812) | 2.68301721 |
145 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.68172854 |
146 | calcium ion-dependent exocytosis (GO:0017156) | 2.66416169 |
147 | regulation of neurotransmitter secretion (GO:0046928) | 2.65927595 |
148 | dendritic spine organization (GO:0097061) | 2.65606873 |
149 | cellular potassium ion homeostasis (GO:0030007) | 2.65321022 |
150 | synaptic transmission, glutamatergic (GO:0035249) | 2.65172101 |
151 | positive regulation of hormone secretion (GO:0046887) | 2.64121273 |
152 | organelle transport along microtubule (GO:0072384) | 2.61476430 |
153 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.60758428 |
154 | regulation of neurotransmitter levels (GO:0001505) | 2.60569385 |
155 | proline transport (GO:0015824) | 2.59763160 |
156 | membrane repolarization during action potential (GO:0086011) | 2.58687081 |
157 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.58222449 |
158 | positive regulation of amine transport (GO:0051954) | 2.58084982 |
159 | mechanosensory behavior (GO:0007638) | 2.56790239 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.64415901 |
2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.10200393 |
3 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.96616862 |
4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82721246 |
5 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.76901217 |
6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.71041205 |
7 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.70824485 |
8 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.68858016 |
9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.65805790 |
10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.55779169 |
11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50670708 |
12 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.46657357 |
13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.42748989 |
14 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.38567692 |
15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.36455232 |
16 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35941196 |
17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.33017156 |
18 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27690637 |
19 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.26080436 |
20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.20288036 |
21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17570215 |
22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.15575147 |
23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.15575147 |
24 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.15574419 |
25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.06256580 |
26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.05395107 |
27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.04105557 |
28 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.01611038 |
29 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94168877 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.87936368 |
31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.79184490 |
32 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71212400 |
33 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.70578800 |
34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.69917446 |
35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.63898697 |
36 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.60294500 |
37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.59883136 |
38 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.59634161 |
39 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.56946395 |
40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51213329 |
41 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.47553517 |
42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.39447453 |
43 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38182810 |
44 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.33692755 |
45 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.25174729 |
46 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.24897389 |
47 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23049154 |
48 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22677867 |
49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.19288309 |
50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.17949164 |
51 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16907635 |
52 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.15665593 |
53 | AR_19668381_ChIP-Seq_PC3_Human | 1.14090220 |
54 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13703387 |
55 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.13372930 |
56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12445597 |
57 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.11155030 |
58 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10552098 |
59 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.10380324 |
60 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.10114764 |
61 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.10008550 |
62 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.05626384 |
63 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04013052 |
64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03777557 |
65 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02800694 |
66 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02065362 |
67 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01227133 |
68 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.97313911 |
69 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96132841 |
70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93095816 |
71 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.92781533 |
72 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92736010 |
73 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.92693585 |
74 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.91809691 |
75 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.91491599 |
76 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91353444 |
77 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91336343 |
78 | * REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.89809981 |
79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89538361 |
80 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89044241 |
81 | P68_20966046_ChIP-Seq_HELA_Human | 0.88763252 |
82 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88491114 |
83 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.88383387 |
84 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87177289 |
85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87107144 |
86 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86965977 |
87 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.86906415 |
88 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85703824 |
89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83743190 |
90 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83343000 |
91 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.83100615 |
92 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.82064609 |
93 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.82036110 |
94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.81962264 |
95 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.81034402 |
96 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.80889925 |
97 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.80466645 |
98 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.80371864 |
99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78828745 |
100 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.78423043 |
101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77705413 |
102 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.77277547 |
103 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.77183734 |
104 | TCF4_23295773_ChIP-Seq_U87_Human | 0.77174379 |
105 | AR_25329375_ChIP-Seq_VCAP_Human | 0.76645865 |
106 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.76191654 |
107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.76058813 |
108 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75587644 |
109 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.75575367 |
110 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.75540673 |
111 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.75121868 |
112 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.75107682 |
113 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.75070687 |
114 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.75058517 |
115 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74957372 |
116 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.74507348 |
117 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.74079797 |
118 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.73886688 |
119 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73624880 |
120 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.73285386 |
121 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.73140988 |
122 | P300_19829295_ChIP-Seq_ESCs_Human | 0.73062459 |
123 | SOX3_22085726_ChIP-Seq_NPCs_Mouse | 0.70175939 |
124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.69164948 |
125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.68622925 |
126 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.68036253 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 4.01748771 |
2 | MP0000013_abnormal_adipose_tissue | 4.00925003 |
3 | MP0002909_abnormal_adrenal_gland | 3.74566544 |
4 | MP0004270_analgesia | 3.55629473 |
5 | MP0003283_abnormal_digestive_organ | 3.43587134 |
6 | MP0005645_abnormal_hypothalamus_physiol | 3.17420096 |
7 | MP0005379_endocrine/exocrine_gland_phen | 2.98960481 |
8 | MP0003635_abnormal_synaptic_transmissio | 2.84888161 |
9 | MP0009780_abnormal_chondrocyte_physiolo | 2.79985785 |
10 | MP0003183_abnormal_peptide_metabolism | 2.64810163 |
11 | MP0003122_maternal_imprinting | 2.64397502 |
12 | MP0003880_abnormal_central_pattern | 2.51490315 |
13 | MP0004043_abnormal_pH_regulation | 2.40573291 |
14 | MP0010386_abnormal_urinary_bladder | 2.36047537 |
15 | MP0002734_abnormal_mechanical_nocicepti | 2.27143119 |
16 | MP0002837_dystrophic_cardiac_calcinosis | 2.21528523 |
17 | MP0009745_abnormal_behavioral_response | 2.20821920 |
18 | MP0002063_abnormal_learning/memory/cond | 2.19323563 |
19 | MP0001944_abnormal_pancreas_morphology | 2.18863906 |
20 | MP0002693_abnormal_pancreas_physiology | 2.17600848 |
21 | MP0002733_abnormal_thermal_nociception | 2.15175094 |
22 | MP0003195_calcinosis | 2.14959129 |
23 | MP0002064_seizures | 2.11562379 |
24 | MP0000003_abnormal_adipose_tissue | 1.95782362 |
25 | MP0002272_abnormal_nervous_system | 1.95470855 |
26 | * MP0002572_abnormal_emotion/affect_behav | 1.94034556 |
27 | MP0001968_abnormal_touch/_nociception | 1.87253705 |
28 | MP0001970_abnormal_pain_threshold | 1.83339425 |
29 | MP0005646_abnormal_pituitary_gland | 1.80049504 |
30 | MP0009046_muscle_twitch | 1.78407225 |
31 | MP0005423_abnormal_somatic_nervous | 1.77447919 |
32 | MP0002822_catalepsy | 1.77424157 |
33 | MP0002638_abnormal_pupillary_reflex | 1.74461641 |
34 | MP0002163_abnormal_gland_morphology | 1.73721022 |
35 | MP0008961_abnormal_basal_metabolism | 1.73354052 |
36 | MP0001502_abnormal_circadian_rhythm | 1.71080907 |
37 | MP0006276_abnormal_autonomic_nervous | 1.69073804 |
38 | MP0002877_abnormal_melanocyte_morpholog | 1.68532047 |
39 | MP0002735_abnormal_chemical_nociception | 1.63541109 |
40 | MP0006072_abnormal_retinal_apoptosis | 1.59485819 |
41 | MP0001986_abnormal_taste_sensitivity | 1.54003264 |
42 | MP0003787_abnormal_imprinting | 1.51499787 |
43 | MP0002184_abnormal_innervation | 1.50751999 |
44 | MP0004858_abnormal_nervous_system | 1.48832412 |
45 | MP0000678_abnormal_parathyroid_gland | 1.47972151 |
46 | MP0001486_abnormal_startle_reflex | 1.47934539 |
47 | MP0002557_abnormal_social/conspecific_i | 1.47896049 |
48 | MP0000955_abnormal_spinal_cord | 1.45510864 |
49 | MP0002078_abnormal_glucose_homeostasis | 1.44682006 |
50 | MP0001188_hyperpigmentation | 1.44649556 |
51 | MP0001501_abnormal_sleep_pattern | 1.43691050 |
52 | MP0003879_abnormal_hair_cell | 1.42969280 |
53 | MP0003690_abnormal_glial_cell | 1.39360215 |
54 | MP0003329_amyloid_beta_deposits | 1.39177589 |
55 | MP0004811_abnormal_neuron_physiology | 1.30696490 |
56 | MP0002067_abnormal_sensory_capabilities | 1.26494223 |
57 | MP0001529_abnormal_vocalization | 1.24474260 |
58 | MP0000920_abnormal_myelination | 1.23274199 |
59 | MP0008569_lethality_at_weaning | 1.22990062 |
60 | MP0004885_abnormal_endolymph | 1.22753231 |
61 | MP0002736_abnormal_nociception_after | 1.19697636 |
62 | MP0001440_abnormal_grooming_behavior | 1.19137491 |
63 | MP0005220_abnormal_exocrine_pancreas | 1.17990424 |
64 | MP0003633_abnormal_nervous_system | 1.15458349 |
65 | MP0001765_abnormal_ion_homeostasis | 1.15453664 |
66 | MP0004924_abnormal_behavior | 1.13934153 |
67 | MP0005386_behavior/neurological_phenoty | 1.13934153 |
68 | MP0004742_abnormal_vestibular_system | 1.09245354 |
69 | MP0003172_abnormal_lysosome_physiology | 1.09154264 |
70 | MP0005535_abnormal_body_temperature | 1.08912295 |
71 | MP0000631_abnormal_neuroendocrine_gland | 1.07914304 |
72 | MP0003953_abnormal_hormone_level | 1.04848259 |
73 | MP0004145_abnormal_muscle_electrophysio | 1.04413418 |
74 | MP0002882_abnormal_neuron_morphology | 1.02863143 |
75 | MP0001963_abnormal_hearing_physiology | 1.02314032 |
76 | MP0003123_paternal_imprinting | 1.01830335 |
77 | MP0001984_abnormal_olfaction | 1.01462098 |
78 | MP0003959_abnormal_lean_body | 1.01316407 |
79 | * MP0002066_abnormal_motor_capabilities/c | 1.00847018 |
80 | MP0002234_abnormal_pharynx_morphology | 1.00000198 |
81 | MP0002069_abnormal_eating/drinking_beha | 0.99910169 |
82 | MP0002751_abnormal_autonomic_nervous | 0.98198731 |
83 | MP0005551_abnormal_eye_electrophysiolog | 0.96752517 |
84 | MP0008877_abnormal_DNA_methylation | 0.95049341 |
85 | MP0000604_amyloidosis | 0.93724450 |
86 | MP0000639_abnormal_adrenal_gland | 0.92445046 |
87 | MP0003121_genomic_imprinting | 0.91672814 |
88 | MP0001177_atelectasis | 0.91326983 |
89 | MP0003632_abnormal_nervous_system | 0.89598215 |
90 | MP0004142_abnormal_muscle_tone | 0.89575025 |
91 | MP0002876_abnormal_thyroid_physiology | 0.87502872 |
92 | MP0002752_abnormal_somatic_nervous | 0.86075422 |
93 | MP0002229_neurodegeneration | 0.84427533 |
94 | MP0000462_abnormal_digestive_system | 0.83502677 |
95 | MP0000778_abnormal_nervous_system | 0.82356090 |
96 | MP0001756_abnormal_urination | 0.79668551 |
97 | MP0003634_abnormal_glial_cell | 0.79261042 |
98 | MP0001905_abnormal_dopamine_level | 0.79047195 |
99 | MP0002653_abnormal_ependyma_morphology | 0.78595418 |
100 | MP0001485_abnormal_pinna_reflex | 0.77609903 |
101 | MP0000026_abnormal_inner_ear | 0.77395790 |
102 | MP0005448_abnormal_energy_balance | 0.77189337 |
103 | MP0005167_abnormal_blood-brain_barrier | 0.75849114 |
104 | MP0002928_abnormal_bile_duct | 0.74790980 |
105 | MP0000230_abnormal_systemic_arterial | 0.73467344 |
106 | MP0001299_abnormal_eye_distance/ | 0.73378701 |
107 | MP0003631_nervous_system_phenotype | 0.73113109 |
108 | MP0005253_abnormal_eye_physiology | 0.69049813 |
109 | MP0002249_abnormal_larynx_morphology | 0.68989025 |
110 | MP0005084_abnormal_gallbladder_morpholo | 0.68066295 |
111 | MP0005623_abnormal_meninges_morphology | 0.68031152 |
112 | MP0003938_abnormal_ear_development | 0.67989971 |
113 | MP0002152_abnormal_brain_morphology | 0.67869334 |
114 | MP0001664_abnormal_digestion | 0.67532350 |
115 | MP0003861_abnormal_nervous_system | 0.67497639 |
116 | MP0004085_abnormal_heartbeat | 0.67417600 |
117 | MP0000681_abnormal_thyroid_gland | 0.67023871 |
118 | MP0002896_abnormal_bone_mineralization | 0.66131342 |
119 | MP0005375_adipose_tissue_phenotype | 0.65537861 |
120 | MP0005499_abnormal_olfactory_system | 0.64837786 |
121 | MP0005394_taste/olfaction_phenotype | 0.64837786 |
122 | MP0001346_abnormal_lacrimal_gland | 0.64194808 |
123 | MP0003119_abnormal_digestive_system | 0.63703513 |
124 | MP0003137_abnormal_impulse_conducting | 0.62627215 |
125 | MP0008872_abnormal_physiological_respon | 0.62136941 |
126 | MP0004133_heterotaxia | 0.62132803 |
127 | MP0000566_synostosis | 0.60078929 |
128 | MP0001943_abnormal_respiration | 0.58898866 |
129 | MP0008874_decreased_physiological_sensi | 0.58455273 |
130 | MP0010769_abnormal_survival | 0.56392400 |
131 | MP0010770_preweaning_lethality | 0.54935482 |
132 | MP0002082_postnatal_lethality | 0.54935482 |
133 | MP0010768_mortality/aging | 0.53103177 |
134 | MP0004130_abnormal_muscle_cell | 0.51956672 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 6.69980471 |
2 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.66464820 |
3 | Hypoglycemic seizures (HP:0002173) | 5.50885265 |
4 | Symptomatic seizures (HP:0011145) | 4.85677134 |
5 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 4.73553536 |
6 | Visual hallucinations (HP:0002367) | 4.51092954 |
7 | Agitation (HP:0000713) | 4.05550307 |
8 | Myokymia (HP:0002411) | 4.04627720 |
9 | Hypoglycemic coma (HP:0001325) | 4.03183050 |
10 | Polyphagia (HP:0002591) | 3.91181682 |
11 | Diplopia (HP:0000651) | 3.61997971 |
12 | Abnormality of binocular vision (HP:0011514) | 3.61997971 |
13 | Pheochromocytoma (HP:0002666) | 3.60917758 |
14 | Spastic gait (HP:0002064) | 3.57344063 |
15 | Late onset (HP:0003584) | 3.52600590 |
16 | Focal motor seizures (HP:0011153) | 3.51221822 |
17 | Mutism (HP:0002300) | 3.43471935 |
18 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.40825498 |
19 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.40825498 |
20 | Hyperglycemia (HP:0003074) | 3.40554814 |
21 | Ketoacidosis (HP:0001993) | 3.38361867 |
22 | Supranuclear gaze palsy (HP:0000605) | 3.33674082 |
23 | Retinal atrophy (HP:0001105) | 3.23787468 |
24 | Large for gestational age (HP:0001520) | 3.20492620 |
25 | Neuroendocrine neoplasm (HP:0100634) | 3.15783393 |
26 | Depression (HP:0000716) | 3.15634090 |
27 | Menstrual irregularities (HP:0000858) | 3.15505299 |
28 | Hyperparathyroidism (HP:0000843) | 3.14158339 |
29 | Hypercortisolism (HP:0001578) | 3.13041901 |
30 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.12495031 |
31 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.11682099 |
32 | Akinesia (HP:0002304) | 3.09030050 |
33 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.08768045 |
34 | Intention tremor (HP:0002080) | 3.05921623 |
35 | Papilledema (HP:0001085) | 3.02816330 |
36 | Cerebral hypomyelination (HP:0006808) | 3.01424815 |
37 | Amblyopia (HP:0000646) | 2.99235941 |
38 | Anxiety (HP:0000739) | 2.98318195 |
39 | Urinary urgency (HP:0000012) | 2.86696775 |
40 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.85250975 |
41 | EEG with generalized epileptiform discharges (HP:0011198) | 2.84926453 |
42 | Decreased circulating renin level (HP:0003351) | 2.84455112 |
43 | Sleep apnea (HP:0010535) | 2.81846066 |
44 | Focal seizures (HP:0007359) | 2.81786500 |
45 | Epileptiform EEG discharges (HP:0011182) | 2.78495240 |
46 | Hypsarrhythmia (HP:0002521) | 2.78368398 |
47 | Delusions (HP:0000746) | 2.77013049 |
48 | Abnormality of the corticospinal tract (HP:0002492) | 2.76137756 |
49 | Ankle clonus (HP:0011448) | 2.76038708 |
50 | Atonic seizures (HP:0010819) | 2.75772914 |
51 | Dysautonomia (HP:0002459) | 2.64726061 |
52 | Dysmetria (HP:0001310) | 2.62516440 |
53 | Dysostosis multiplex (HP:0000943) | 2.62414760 |
54 | Epileptic encephalopathy (HP:0200134) | 2.61273904 |
55 | Hyperthyroidism (HP:0000836) | 2.57818766 |
56 | Hemiparesis (HP:0001269) | 2.55537050 |
57 | Craniofacial dystonia (HP:0012179) | 2.52000110 |
58 | Status epilepticus (HP:0002133) | 2.49636750 |
59 | Peripheral hypomyelination (HP:0007182) | 2.46329171 |
60 | Absence seizures (HP:0002121) | 2.46193780 |
61 | Ventricular fibrillation (HP:0001663) | 2.45669155 |
62 | Neurofibrillary tangles (HP:0002185) | 2.43895319 |
63 | Generalized tonic-clonic seizures (HP:0002069) | 2.43648682 |
64 | Restlessness (HP:0000711) | 2.41986701 |
65 | Growth hormone excess (HP:0000845) | 2.40844756 |
66 | Obstructive sleep apnea (HP:0002870) | 2.38189172 |
67 | Abnormal pancreas size (HP:0012094) | 2.37277298 |
68 | Neuronal loss in central nervous system (HP:0002529) | 2.37152920 |
69 | Lower limb muscle weakness (HP:0007340) | 2.36141404 |
70 | Congenital malformation of the right heart (HP:0011723) | 2.35041280 |
71 | Double outlet right ventricle (HP:0001719) | 2.35041280 |
72 | Action tremor (HP:0002345) | 2.32455469 |
73 | Annular pancreas (HP:0001734) | 2.32175747 |
74 | Progressive cerebellar ataxia (HP:0002073) | 2.31380379 |
75 | Drooling (HP:0002307) | 2.31241050 |
76 | Failure to thrive in infancy (HP:0001531) | 2.30731945 |
77 | Adrenal overactivity (HP:0002717) | 2.29497607 |
78 | Poor eye contact (HP:0000817) | 2.28082871 |
79 | Neoplasm of the heart (HP:0100544) | 2.26236463 |
80 | Mucopolysacchariduria (HP:0008155) | 2.24813119 |
81 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.24813119 |
82 | Increased circulating renin level (HP:0000848) | 2.24266684 |
83 | Apathy (HP:0000741) | 2.21592097 |
84 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.21314509 |
85 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.21314509 |
86 | Type II lissencephaly (HP:0007260) | 2.20381281 |
87 | Tetraplegia (HP:0002445) | 2.19689512 |
88 | Poor suck (HP:0002033) | 2.18495711 |
89 | Truncal ataxia (HP:0002078) | 2.17691383 |
90 | Hypokalemia (HP:0002900) | 2.17605597 |
91 | Hemiplegia (HP:0002301) | 2.16112806 |
92 | Limb dystonia (HP:0002451) | 2.14396460 |
93 | Hypotension (HP:0002615) | 2.14275684 |
94 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.13788805 |
95 | Dysdiadochokinesis (HP:0002075) | 2.13471982 |
96 | Dialeptic seizures (HP:0011146) | 2.11869293 |
97 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.11792751 |
98 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.11792751 |
99 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.11792751 |
100 | Excessive salivation (HP:0003781) | 2.10680571 |
101 | Abnormality of renin-angiotensin system (HP:0000847) | 2.10099284 |
102 | Febrile seizures (HP:0002373) | 2.09971209 |
103 | Cerebral inclusion bodies (HP:0100314) | 2.09032136 |
104 | Diminished motivation (HP:0000745) | 2.07856985 |
105 | Broad-based gait (HP:0002136) | 2.07670050 |
106 | Amyotrophic lateral sclerosis (HP:0007354) | 2.07290104 |
107 | Abnormality of the lower motor neuron (HP:0002366) | 2.06976108 |
108 | Psychosis (HP:0000709) | 2.06961820 |
109 | Hypoventilation (HP:0002791) | 2.06167390 |
110 | Orthostatic hypotension (HP:0001278) | 2.04660449 |
111 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03869038 |
112 | Fetal akinesia sequence (HP:0001989) | 2.03504456 |
113 | Torticollis (HP:0000473) | 2.02196790 |
114 | Postural tremor (HP:0002174) | 2.01640389 |
115 | Impaired smooth pursuit (HP:0007772) | 2.01382830 |
116 | Hyperphosphatemia (HP:0002905) | 2.01364867 |
117 | Spastic tetraplegia (HP:0002510) | 2.01252656 |
118 | Hypothermia (HP:0002045) | 2.00606440 |
119 | Hyperkalemia (HP:0002153) | 2.00332187 |
120 | Absent speech (HP:0001344) | 1.98202934 |
121 | Retinal dysplasia (HP:0007973) | 1.95987544 |
122 | Macroorchidism (HP:0000053) | 1.94552186 |
123 | Impaired social interactions (HP:0000735) | 1.94303466 |
124 | Abnormal social behavior (HP:0012433) | 1.94303466 |
125 | Focal dystonia (HP:0004373) | 1.94230516 |
126 | Cortical visual impairment (HP:0100704) | 1.93959776 |
127 | Spastic tetraparesis (HP:0001285) | 1.93834130 |
128 | Hyperventilation (HP:0002883) | 1.93231427 |
129 | Progressive neurologic deterioration (HP:0002344) | 1.92944363 |
130 | CNS hypomyelination (HP:0003429) | 1.92846344 |
131 | Gait imbalance (HP:0002141) | 1.92651880 |
132 | Split foot (HP:0001839) | 1.92240898 |
133 | Megalencephaly (HP:0001355) | 1.91685591 |
134 | Rigidity (HP:0002063) | 1.91140308 |
135 | Abnormality of potassium homeostasis (HP:0011042) | 1.90003400 |
136 | Truncus arteriosus (HP:0001660) | 1.88330669 |
137 | Clonus (HP:0002169) | 1.88183539 |
138 | Blue irides (HP:0000635) | 1.86856550 |
139 | Testicular neoplasm (HP:0010788) | 1.86127588 |
140 | Postural instability (HP:0002172) | 1.85726798 |
141 | Choreoathetosis (HP:0001266) | 1.85286264 |
142 | Gout (HP:0001997) | 1.84653903 |
143 | Hypoplasia of the corpus callosum (HP:0002079) | 1.84572489 |
144 | Prominent metopic ridge (HP:0005487) | 1.84426229 |
145 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.84384616 |
146 | Bundle branch block (HP:0011710) | 1.83980773 |
147 | Prolonged QT interval (HP:0001657) | 1.83201429 |
148 | Insomnia (HP:0100785) | 1.81941033 |
149 | Congenital glaucoma (HP:0001087) | 1.81760737 |
150 | Abnormal eating behavior (HP:0100738) | 1.80985873 |
151 | Impaired vibratory sensation (HP:0002495) | 1.80928141 |
152 | Muscular hypotonia of the trunk (HP:0008936) | 1.80407627 |
153 | Incomplete penetrance (HP:0003829) | 1.79466935 |
154 | Specific learning disability (HP:0001328) | 1.79372889 |
155 | Insulin resistance (HP:0000855) | 1.77699579 |
156 | Bradykinesia (HP:0002067) | 1.77120772 |
157 | Abnormal EKG (HP:0003115) | 1.76793851 |
158 | Ketosis (HP:0001946) | 1.76727871 |
159 | Stereotypic behavior (HP:0000733) | 1.73577746 |
160 | Diminished movement (HP:0002374) | 1.73450608 |
161 | Rapidly progressive (HP:0003678) | 1.72544045 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAPK15 | 5.48061222 |
2 | WNK3 | 4.81272682 |
3 | INSRR | 3.84440673 |
4 | NTRK3 | 3.46330898 |
5 | PRKD3 | 2.78693541 |
6 | NTRK1 | 2.76658353 |
7 | MAP3K9 | 2.73281157 |
8 | UHMK1 | 2.69928943 |
9 | PASK | 2.45024659 |
10 | WNK4 | 2.26427741 |
11 | MAP3K2 | 2.14776855 |
12 | EPHA4 | 2.04587572 |
13 | KSR2 | 2.02100231 |
14 | PLK2 | 1.77979472 |
15 | HIPK2 | 1.77418697 |
16 | PAK6 | 1.76365043 |
17 | MINK1 | 1.76306657 |
18 | PIK3CG | 1.65707931 |
19 | MARK1 | 1.62891690 |
20 | DAPK2 | 1.60950549 |
21 | CAMKK2 | 1.59847671 |
22 | SIK2 | 1.54496026 |
23 | ARAF | 1.51430615 |
24 | MAP3K1 | 1.49323554 |
25 | MAP3K4 | 1.48610900 |
26 | FRK | 1.46327348 |
27 | NTRK2 | 1.36307698 |
28 | CAMKK1 | 1.35359122 |
29 | PAK3 | 1.33767153 |
30 | WNK1 | 1.30987445 |
31 | CDK5 | 1.24654919 |
32 | DYRK2 | 1.21634812 |
33 | MAP2K7 | 1.16560153 |
34 | GRK5 | 1.11975802 |
35 | PINK1 | 1.11414210 |
36 | PRKCH | 1.07666225 |
37 | SCYL2 | 1.07521277 |
38 | TAOK3 | 1.05567329 |
39 | PKN1 | 1.02600756 |
40 | MAP3K12 | 1.01345153 |
41 | DAPK1 | 1.01283121 |
42 | CSNK1G3 | 0.96436778 |
43 | BRAF | 0.93173919 |
44 | MAP3K11 | 0.92616982 |
45 | PRKCG | 0.91911163 |
46 | MAP2K4 | 0.91834039 |
47 | CDC42BPA | 0.87677734 |
48 | KSR1 | 0.86413397 |
49 | CSNK1A1L | 0.83660243 |
50 | STK11 | 0.83569147 |
51 | ERN1 | 0.82700089 |
52 | PRKD2 | 0.79841299 |
53 | STK38 | 0.78416953 |
54 | DYRK1B | 0.77619206 |
55 | FER | 0.77086655 |
56 | PTK2 | 0.76972509 |
57 | TAOK1 | 0.76056787 |
58 | MAPK12 | 0.74207162 |
59 | SGK2 | 0.73259716 |
60 | ALK | 0.71141757 |
61 | RET | 0.70738551 |
62 | PDGFRA | 0.70492436 |
63 | PHKG1 | 0.69330306 |
64 | PHKG2 | 0.69330306 |
65 | BRSK1 | 0.68364901 |
66 | SGK223 | 0.66614263 |
67 | SGK494 | 0.66614263 |
68 | CSNK1G1 | 0.65907679 |
69 | FGFR2 | 0.64359667 |
70 | LIMK1 | 0.64153369 |
71 | MARK2 | 0.63903571 |
72 | DYRK1A | 0.63252488 |
73 | CDK14 | 0.62664725 |
74 | MAP3K13 | 0.62354612 |
75 | TNK2 | 0.60773399 |
76 | CDK19 | 0.60541141 |
77 | RIPK4 | 0.60065526 |
78 | CAMK2B | 0.59647469 |
79 | MAPK13 | 0.57526683 |
80 | CAMK4 | 0.55493867 |
81 | PNCK | 0.55476377 |
82 | CAMK1 | 0.55429590 |
83 | LATS2 | 0.55043604 |
84 | TESK1 | 0.54786166 |
85 | SGK3 | 0.54308737 |
86 | CAMK2A | 0.53671135 |
87 | MAP4K2 | 0.52977512 |
88 | MAP2K6 | 0.52754382 |
89 | CAMK2D | 0.52594952 |
90 | TNIK | 0.52527139 |
91 | MAP2K1 | 0.52171044 |
92 | FES | 0.50627305 |
93 | CDK18 | 0.49733144 |
94 | PRKCE | 0.49482981 |
95 | CDK15 | 0.48892572 |
96 | ICK | 0.47932529 |
97 | CDK11A | 0.45441029 |
98 | PDPK1 | 0.42766389 |
99 | PDK1 | 0.42115778 |
100 | MAPK10 | 0.41090367 |
101 | ROCK2 | 0.40974739 |
102 | SGK1 | 0.40883390 |
103 | MAP2K2 | 0.40691432 |
104 | EPHA3 | 0.40080335 |
105 | LMTK2 | 0.39959887 |
106 | OXSR1 | 0.39059645 |
107 | DAPK3 | 0.38608796 |
108 | PRKAA1 | 0.38511730 |
109 | RPS6KA3 | 0.38451803 |
110 | PRKCI | 0.37978338 |
111 | PRKCA | 0.37785870 |
112 | BCR | 0.37744628 |
113 | RPS6KA2 | 0.36422758 |
114 | CSNK1D | 0.36041182 |
115 | CSNK1G2 | 0.35710884 |
116 | RIPK1 | 0.34438814 |
117 | FLT3 | 0.33858154 |
118 | CSNK1E | 0.33671429 |
119 | PRKACG | 0.32956655 |
120 | NEK6 | 0.32740725 |
121 | ADRBK1 | 0.32729775 |
122 | ERBB2 | 0.31770339 |
123 | MAPK8 | 0.31575679 |
124 | CSNK1A1 | 0.31479433 |
125 | CAMK2G | 0.30975453 |
126 | PRKACA | 0.30518008 |
127 | PRPF4B | 0.29933262 |
128 | CASK | 0.29250736 |
129 | PRKCZ | 0.28476892 |
130 | CAMK1G | 0.28363790 |
131 | TYRO3 | 0.27121762 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.20063775 |
2 | Insulin secretion_Homo sapiens_hsa04911 | 3.43709666 |
3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.97645652 |
4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.53771665 |
5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.31142017 |
6 | Protein export_Homo sapiens_hsa03060 | 2.28704409 |
7 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.28123590 |
8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.22532752 |
9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.22117257 |
10 | Cocaine addiction_Homo sapiens_hsa05030 | 2.21672390 |
11 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.04505052 |
12 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 2.03943365 |
13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.99398191 |
14 | Nicotine addiction_Homo sapiens_hsa05033 | 1.95074328 |
15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.90348222 |
16 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.86870891 |
17 | Morphine addiction_Homo sapiens_hsa05032 | 1.81338546 |
18 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.79367187 |
19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.77859071 |
20 | Taste transduction_Homo sapiens_hsa04742 | 1.74364764 |
21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.69643632 |
22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.65463175 |
23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.61923574 |
24 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.60723745 |
25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47330299 |
26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.44230387 |
27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43194769 |
28 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.42666956 |
29 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.41109753 |
30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.37915323 |
31 | Salivary secretion_Homo sapiens_hsa04970 | 1.37375161 |
32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.29123136 |
33 | Renin secretion_Homo sapiens_hsa04924 | 1.28538014 |
34 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17824035 |
35 | Long-term depression_Homo sapiens_hsa04730 | 1.16901068 |
36 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.16607995 |
37 | Prion diseases_Homo sapiens_hsa05020 | 1.08770681 |
38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.08506978 |
39 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.07104954 |
40 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.06392672 |
41 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.06310212 |
42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.04931566 |
43 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03229167 |
44 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.02071383 |
45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02029350 |
46 | Gap junction_Homo sapiens_hsa04540 | 1.01149954 |
47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00443127 |
48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98479405 |
49 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97804074 |
50 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.94473901 |
51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94333132 |
52 | Lysosome_Homo sapiens_hsa04142 | 0.93995786 |
53 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91569807 |
54 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.90535685 |
55 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.88035585 |
56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.83402034 |
57 | Melanogenesis_Homo sapiens_hsa04916 | 0.81983750 |
58 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80209439 |
59 | Alcoholism_Homo sapiens_hsa05034 | 0.79750121 |
60 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.79451751 |
61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.79163349 |
62 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.76502042 |
63 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74171503 |
64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.72047475 |
65 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.71076339 |
66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68370545 |
67 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.66517155 |
68 | Glioma_Homo sapiens_hsa05214 | 0.65322431 |
69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62172026 |
70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61355689 |
71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60614246 |
72 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.58347546 |
73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54007132 |
74 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53726875 |
75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.53628504 |
76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53158101 |
77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.52036565 |
78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51679500 |
79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51346385 |
80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50294607 |
81 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.47850017 |
82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.47598216 |
83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.47132346 |
84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.46896383 |
85 | Endocytosis_Homo sapiens_hsa04144 | 0.46731158 |
86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.46347241 |
87 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46240351 |
88 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45963041 |
89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44570197 |
90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42761931 |
91 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41674637 |
92 | Axon guidance_Homo sapiens_hsa04360 | 0.41333926 |
93 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41029783 |
94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.38422943 |
95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.37919794 |
96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.37122424 |
97 | Bile secretion_Homo sapiens_hsa04976 | 0.35828230 |
98 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35414892 |
99 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35006263 |
100 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34927207 |
101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34494492 |
102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34021206 |
103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.33939127 |
104 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33845379 |
105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33475799 |
106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33354277 |
107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31755934 |
108 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.31610275 |
109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.30473676 |
110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30286840 |
111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.30193112 |
112 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29817182 |
113 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29399708 |
114 | Insulin resistance_Homo sapiens_hsa04931 | 0.28074275 |
115 | Phototransduction_Homo sapiens_hsa04744 | 0.27980076 |
116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27605012 |
117 | ABC transporters_Homo sapiens_hsa02010 | 0.26097078 |
118 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23245374 |